177 Lu-PSMA radioligand therapy effectiveness in metastatic castration-resistant prostate cancer: An updated systematic review and meta-analysis.

Mohammad S SadaghianiSara SheikhbahaeiRudolf A WernerKenneth J PientaMartin G PomperMichael A GorinLilja B SolnesSteven P Rowe

Published in: The Prostate (2022)

This is the first meta-analysis to aggregate the recent randomized controlled trials of PRLT which shows CRPC patients had a higher response to therapy after PRLT compared to controls.

Keyphrases

systematic review
randomized controlled trial
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
meta analyses
small cell lung cancer
pet ct
peritoneal dialysis
patient reported outcomes
computed tomography
mesenchymal stem cells
cell therapy
smoking cessation
double blind